331 related articles for article (PubMed ID: 12402164)
1. Enhanced green fluorescent protein expression may be used to monitor murine coronavirus spread in vitro and in the mouse central nervous system.
Das Sarma J; Scheen E; Seo SH; Koval M; Weiss SR
J Neurovirol; 2002 Oct; 8(5):381-91. PubMed ID: 12402164
[TBL] [Abstract][Full Text] [Related]
2. Pathogenesis of chimeric MHV4/MHV-A59 recombinant viruses: the murine coronavirus spike protein is a major determinant of neurovirulence.
Phillips JJ; Chua MM; Lavi E; Weiss SR
J Virol; 1999 Sep; 73(9):7752-60. PubMed ID: 10438865
[TBL] [Abstract][Full Text] [Related]
3. Targeted recombination within the spike gene of murine coronavirus mouse hepatitis virus-A59: Q159 is a determinant of hepatotropism.
Leparc-Goffart I; Hingley ST; Chua MM; Phillips J; Lavi E; Weiss SR
J Virol; 1998 Dec; 72(12):9628-36. PubMed ID: 9811696
[TBL] [Abstract][Full Text] [Related]
4. Effects of an epitope-specific CD8+ T-cell response on murine coronavirus central nervous system disease: protection from virus replication and antigen spread and selection of epitope escape mutants.
Chua MM; MacNamara KC; San Mateo L; Shen H; Weiss SR
J Virol; 2004 Feb; 78(3):1150-9. PubMed ID: 14722270
[TBL] [Abstract][Full Text] [Related]
5. Multiple regions of the murine coronavirus spike glycoprotein influence neurovirulence.
Phillips JJ; Chua M; Seo SH; Weiss SR
J Neurovirol; 2001 Oct; 7(5):421-31. PubMed ID: 11582514
[TBL] [Abstract][Full Text] [Related]
6. Murine coronavirus spike protein determines the ability of the virus to replicate in the liver and cause hepatitis.
Navas S; Seo SH; Chua MM; Das Sarma J; Lavi E; Hingley ST; Weiss SR
J Virol; 2001 Mar; 75(5):2452-7. PubMed ID: 11160748
[TBL] [Abstract][Full Text] [Related]
7. The spike glycoprotein of murine coronavirus MHV-JHM mediates receptor-independent infection and spread in the central nervous systems of Ceacam1a-/- Mice.
Miura TA; Travanty EA; Oko L; Bielefeldt-Ohmann H; Weiss SR; Beauchemin N; Holmes KV
J Virol; 2008 Jan; 82(2):755-63. PubMed ID: 18003729
[TBL] [Abstract][Full Text] [Related]
8. In vitro properties and pathogenesis of A59/MHV4 chimeric mouse hepatitis viruses.
Tsai JC; Weiss SR
Adv Exp Med Biol; 2001; 494():169-72. PubMed ID: 11774464
[No Abstract] [Full Text] [Related]
9. Neuropathogenicity of mouse hepatitis virus JHM isolates differing in hemagglutinin-esterase protein expression.
Yokomori K; Asanaka M; Stohlman SA; Makino S; Shubin RA; Gilmore W; Weiner LP; Wang FI; Lai MM
J Neurovirol; 1995 Dec; 1(5-6):330-9. PubMed ID: 9222375
[TBL] [Abstract][Full Text] [Related]
10. Contributions of the viral genetic background and a single amino acid substitution in an immunodominant CD8+ T-cell epitope to murine coronavirus neurovirulence.
MacNamara KC; Chua MM; Phillips JJ; Weiss SR
J Virol; 2005 Jul; 79(14):9108-18. PubMed ID: 15994805
[TBL] [Abstract][Full Text] [Related]
11. Amino acid substitutions and an insertion in the spike glycoprotein extend the host range of the murine coronavirus MHV-A59.
Thackray LB; Holmes KV
Virology; 2004 Jul; 324(2):510-24. PubMed ID: 15207636
[TBL] [Abstract][Full Text] [Related]
12. The murine coronavirus nucleocapsid gene is a determinant of virulence.
Cowley TJ; Long SY; Weiss SR
J Virol; 2010 Feb; 84(4):1752-63. PubMed ID: 20007284
[TBL] [Abstract][Full Text] [Related]
13. Murine coronavirus evolution in vivo: functional compensation of a detrimental amino acid substitution in the receptor binding domain of the spike glycoprotein.
Navas-Martin S; Hingley ST; Weiss SR
J Virol; 2005 Jun; 79(12):7629-40. PubMed ID: 15919915
[TBL] [Abstract][Full Text] [Related]
14. Mouse hepatitis virus neurovirulence: evidence of a linkage between S glycoprotein expression and immunopathology.
Rempel JD; Murray SJ; Meisner J; Buchmeier MJ
Virology; 2004 Jan; 318(1):45-54. PubMed ID: 14972534
[TBL] [Abstract][Full Text] [Related]
15. The virulence of mouse hepatitis virus strain A59 is not dependent on efficient spike protein cleavage and cell-to-cell fusion.
Hingley ST; Leparc-Goffart I; Seo SH; Tsai JC; Weiss SR
J Neurovirol; 2002 Oct; 8(5):400-10. PubMed ID: 12402166
[TBL] [Abstract][Full Text] [Related]
16. Sequence analysis of the S gene of recombinant MHV-2/A59 coronaviruses reveals three candidate mutations associated with demyelination and hepatitis.
Das Sarma J; Fu L; Hingley ST; Lai MM; Lavi E
J Neurovirol; 2001 Oct; 7(5):432-6. PubMed ID: 11582515
[TBL] [Abstract][Full Text] [Related]
17. Demyelination determinants map to the spike glycoprotein gene of coronavirus mouse hepatitis virus.
Das Sarma J; Fu L; Tsai JC; Weiss SR; Lavi E
J Virol; 2000 Oct; 74(19):9206-13. PubMed ID: 10982367
[TBL] [Abstract][Full Text] [Related]
18. The effect of the T1087N S gene mutation on MHV-A59 pathogenesis.
Das Sarma J; Fu L; Lavi E
Adv Exp Med Biol; 2001; 494():155-7. PubMed ID: 11774461
[No Abstract] [Full Text] [Related]
19. Inactivation of expression of gene 4 of mouse hepatitis virus strain JHM does not affect virulence in the murine CNS.
Ontiveros E; Kuo L; Masters PS; Perlman S
Virology; 2001 Oct; 289(2):230-8. PubMed ID: 11689046
[TBL] [Abstract][Full Text] [Related]
20. Recombinant genomic RNA of coronavirus MHV-A59 after coreplication with a DI RNA containing the MHV-RI spike gene.
Zhang L; Homberger F; Spaan W; Luytjes W
Virology; 1997 Mar; 230(1):93-102. PubMed ID: 9126265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
